Overview

·National Strategic Emerging Industry Cluster

·National Advanced Manufacturing Cluster

·National Neo-Industrialization Demo Base for Biopharma Industry

·Specialized Industrial Cluster of SMEs in Biomedical Outsourcing Services

·China's Largest Production Base for Insulin and Enzyme Preparations

·Demo Zone for Quality Improvement and Efficiency Enhancement of Foreign Trade in Biomedical Industry

Covering eight growth priorities of the pharmaceutical industry:

Biopharmaceuticals:

Chemical Drugs and Traditional Chinese Medicine:

Medical Devices:

CRO Services:

Food & Beverage: